Crowdonomics
All companies
Reset IV logo

Reset IV

Operating

Reset IV, Inc.

Healthcare · Founded 2017

Bringing health and wellness with the touch of a button

Post-money valuation ⓘ
$11.1M
As of Dec 2020 · from Reg CF Offering (2020) · pre-money + amount raised, not a traded price
Total raised
$1,112,254
Crowd $1.1M · Private $41K · 5 rounds since 2017
Latest share price
$1.04
Reg CF · Common Stock · Feb 2020 offering price

Financials

FY2017–FY2022 · from SEC filings · hover any figure for its source
$63K
$30K
2017
$0
−$6K
2018
$1.4M
$24K
2019
$1.6M
−$582K
2020
$4.2M
$83K
2021
$6.8M
−$400K
2022
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2017 reviewed
FY2018 reviewed
FY2019 unaudited
FY2020 unaudited
FY2021 unaudited
FY2022 unaudited
Income statement
Revenue
$62,500
$0
$1,442,423
$1,555,526
$4,152,310
$6,802,429
Cost of goods sold
$0
$0
$227,698
$229,229
$563,731
$785,444
Gross margin
100%
—
84%
85%
86%
88%
Net income
$29,516
-$6,493
$24,476
-$581,968
$83,070
-$399,579
Taxes paid
$0
$0
$0
$0
$0
$0
Balance sheet
Cash
$1,961
$0
$58,946
$459,747
$686,403
$222,810
Accounts receivable
$88,801
$0
$6,720
$0
$0
$0
Total assets
$93,085
$1,140
$251,793
$757,772
$991,134
$8,880,385
Short-term debt
$56,305
$634
$147,876
$252,327
$170,957
$240,972
Long-term debt
$0
$0
$0
$0
$0
$0
Total liabilities
$56,305
$634
$147,876
$252,327
$170,957
$240,972
Other
Headcount
—
2
2
6
—
0

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$9.6M
est. pre-money
$10.0M
pre-money
Section 4(a)(2) · Common · Dec 2019
Reg CF · Common · Feb 2020

Blue bars are the pre-money valuation the company stated for a priced round. Dotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.

Share price over rounds

log scale
$1.04$0.0568$0.0031
Dec 2017Feb 2020
Round offering price or verified disclosed saleDisclosed sale, unverified or year-onlyDown round · Dec 2019 (-99.7%)

Disclosed sales come from the issuer's own filings (prior-offering lines, audited-statement notes) and are amount ÷ securities sold. A down round is a firm point more than 25 % below the previous firm point of the same share class on a comparable basis; the comparison ignores unverified and year-only lines.

Cap table

Share counts as of Dec 31, 2022
ClassOutstandingVotes / shareShare of totalLast price
Common stock11,635,710—100.0%$1.04Feb 2020

Shares outstanding over timein today's share terms

12M5.8M0
Dec 2019Dec 2022
Common stockRound opened

Principal holders% as the filing states it, Feb 27, 2020

  • Daniel Rubenstein100.0%of company
  • Kiarash Mirkia25.0%of company
  • JKS Holdings, Inc.12.6%of company
  • Joe Haro12.6%of company
  • Lori Parks1%of company

Sold to the crowd

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Raised $1.1M / $1.1MInvestors 3,474Post-money $11.1M
Raised $5KEst. pre-money $9.6M

Team

2 people
Daniel Rubenstein
CEO, Principal Executive Officer and Director
Lori A. Parks
Principal Financial Officer and Principal Accounting Officer

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not required3+ reports filed & assets ≤ $10M

Filed 3 of 7 annual reports (FY2019–FY2025)

3,474 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

  • Form C-ARJun 16, 20230001665160-23-001403
    EDGAR
  • Form C-UOct 7, 20220001665160-22-002678
    EDGAR
  • Form C-AR/AJun 17, 20210001665160-21-001079
    EDGAR
  • Form C-ARApr 28, 20210001665160-21-000632
    EDGAR
  • Form C-UJan 4, 20210001665160-21-000002
    EDGAR
  • Form C/AOct 26, 20200001665160-20-001338
    EDGAR
  • Form C/AAug 26, 20200001665160-20-001103
    EDGAR
  • Form C-ARJun 10, 20200001665160-20-000776
    EDGAR
Source: ManualCIK 0001800753Share price $1.04

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.